TickerKhojComparison · NSE · data 2026-11-03
Renol Polychem Limited vs Vineet Laboratories Ltd.
In plain words
Size: Renol Polychem Limited is about 1.1 times the market value of Vineet Laboratories Ltd..
Valuation (P/E): Vineet Laboratories Ltd. 14.4 vs Renol Polychem Limited 6.
Profit growth over 3 years: Renol Polychem Limited 274.2% a year vs Vineet Laboratories Ltd. -3.9% a year.
Debt to equity: Vineet Laboratories Ltd. 0.99 vs Renol Polychem Limited 0.16.
Differences in the numbers, not a recommendation of either stock.
Side by side
19 metrics shown
| RNPL | VINEETLAB | |
|---|---|---|
| Price | ₹63.25 | ₹36.06 |
| Market cap | ₹75 cr | ₹70 cr |
| P/E | 6 | 14.4 |
| P/B | — | — |
| ROE | — | 3.7% |
| ROCE | 17.4% | 15.6% |
| Debt / equity | 0.16 | 0.99 |
| Operating margin | 12.9% | 12.9% |
| Dividend yield | 0.00% | 0.00% |
| Sales growth, 3 years (yearly) | 49.8% | -34.6% |
| Profit growth, 3 years (yearly) | 274.2% | -3.9% |
| 1-year return | -46.8% | -8.3% |
| Revenue, last 12 months | ₹90 cr | ₹62 cr |
| Net profit, last 12 months | ₹8 cr | ₹3 cr |
| Latest quarter | — | Jun 2026 |
| Quarter net profit | — | ₹2 cr |
| Quarter profit vs a year earlier | — | — |
| Promoter holding | — | 5.98% |
| Health check | Strong (7/10) | Average (4.8/10) |
Common questions
Which has a higher P/E, Renol Polychem Limited or Vineet Laboratories Ltd.?
Vineet Laboratories Ltd. trades at the higher P/E (14.4 against 6). A higher P/E means the market pays more for each rupee of past earnings; on its own it does not say which is better.
Which carries more debt?
Vineet Laboratories Ltd. has the higher debt-to-equity ratio (0.99 against 0.16).